ClinicalTrials.gg
Drug

Gevokizumab clinical trials

Also written XOMA 052.

studies test it
21
open now
0
in phase 3
6
first study started
2007

How each study uses gevokizumab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

gevokizumab
13

Development codes

XOMA 052
8

Studies by the year they started

21 studies that test it; most in 2014 (5)

Studies that test gevokizumab, by start year
YearStudies
20072
20092
20104
20111
20122
20134
20145
20221

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
13
Phase 3
6
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 16 · Other 5

XOMA (US) LLC (16) · Institut de Recherches Internationales Servier (2) · University of Zurich (1) · NSABP Foundation Inc (1) · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) (1)

Studies

Open first, then newest update. How each study uses gevokizumab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 21

See all 21 studies that test gevokizumab →

Given beside what is tested · 1 — gevokizumab is usual care or a partner of the new treatment

Codes

What other systems call gevokizumab · ClinicalTrials.gg INT005584

  • MeSH (NLM) C547697gevokizumabConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) QX3JU54GYQGEVOKIZUMABConfirmed FDA, NLM, Wikidata
  • Wikidata Q5554924GevokizumabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C97945GevokizumabOne source FDA
  • DrugBank DB12119One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.